Literature DB >> 25293395

Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study.

Chin-Hsien Lin1, Jou-Wei Lin2, Ying-Chun Liu3, Chia-Hsuin Chang4, Ruey-Meei Wu5.   

Abstract

INTRODUCTION: Constipation is a non-motor symptom of Parkinson's disease (PD). We investigated the association between the severity of constipation and subsequent risk of PD in a population-based sample.
METHODS: 551,324 participants free of PD, dementia, and stroke were retrospectively ascertained between January 1, 2005 and December 31, 2005 using the Taiwan National Health Insurance Research Database. The association between constipation at the beginning of the study and the incidence of PD was examined using a Cox regression model. Information regarding comorbidities and concomitant medications use was adjusted in the proportional hazards models.
RESULTS: After an average follow-up of 5.5 years, 2336 incident PD cases were diagnosed. The crude incidence rate of PD per 1,000,000 person-days was 1.57 for subjects without constipation and 4.04, 5.28, and 12.67 for mild, moderate, and severe constipation, respectively. After adjusting for age, sex, comorbidities, and concomitant medication use, patients with constipation were more likely to develop PD than subjects without constipation; the adjusted hazard ratio (aHR) was 3.28 (95% CI: 2.14-5.03), 3.83 (2.51-5.84), and 4.22 (2.95-6.05) for individual constipation severity categories. Constipation severity was also associated with an increased likelihood of PD in the time-varying analysis; the aHR was 2.84 (2.43-3.33), 5.22 (4.61-5.92), and 10.47 (9.46-11.58) for mild, moderate, and severe constipation, respectively (P < 0.0001). After excluding PD patients diagnosed within 3 years of constipation, the association remained significant.
CONCLUSIONS: Our study suggests that the severity of constipation is associated with a future diagnosis of PD in a dose-dependent manner.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Constipation; Non-motor symptoms; Parkinson's disease; Population study; Pre-motor symptoms

Mesh:

Year:  2014        PMID: 25293395     DOI: 10.1016/j.parkreldis.2014.09.026

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  32 in total

Review 1.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Risk of Parkinson's disease after colectomy: longitudinal follow-up study using a national sample cohort.

Authors:  Young-Ju Kim; Chang-Min Lee; Seongheon Kim; Jae-Won Jang; Seo-Young Lee; Seung-Hwan Lee
Journal:  J Neurol       Date:  2019-11-05       Impact factor: 4.849

3.  Downregulation of neuronal vasoactive intestinal polypeptide in Parkinson's disease and chronic constipation.

Authors:  F Giancola; F Torresan; R Repossi; F Bianco; R Latorre; A Ioannou; M Guarino; U Volta; P Clavenzani; M Mazzoni; R Chiocchetti; F Bazzoli; R A Travagli; C Sternini; R De Giorgio
Journal:  Neurogastroenterol Motil       Date:  2016-11-27       Impact factor: 3.598

4.  High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study.

Authors:  Shin-Chia Tsai; Shiow-Yunn Sheu; Li-Nien Chien; Hsin-Chien Lee; Eunice Jia-Shiow Yuan; Rey-Yue Yuan
Journal:  Br J Clin Pharmacol       Date:  2018-06-19       Impact factor: 4.335

Review 5.  Constipation in Parkinson's Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle?

Authors:  Amol Sharma; Julie Kurek; John C Morgan; Chandramohan Wakade; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2018-01-19

Review 6.  Advances in markers of prodromal Parkinson disease.

Authors:  Ronald B Postuma; Daniela Berg
Journal:  Nat Rev Neurol       Date:  2016-10-27       Impact factor: 42.937

Review 7.  Parkinson's Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects.

Authors:  Chethan Ramprasad; Jane Yellowlees Douglas; Baharak Moshiree
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 8.  Autonomic Dysfunction in Parkinson's Disease.

Authors:  Ronald F Pfeiffer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

9.  Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case-Control Study in an Australian Cohort.

Authors:  Jade E Kenna; Megan C Bakeberg; Anastazja M Gorecki; Alfred Chin Yen Tay; Samantha Winter; Frank L Mastaglia; Ryan S Anderton
Journal:  Mov Disord Clin Pract       Date:  2021-01-05

Review 10.  Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease.

Authors:  Marina Picillo; Paolo Barone; Maria Teresa Pellecchia
Journal:  Mov Disord Clin Pract       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.